SDC1 and hepatocellular carcinoma: Similarly, CCL2-induced human hepatoma cell migration and invasion has been blocked by anti-syndecan-1 and -4 antibodies, but also when hepatoma cells were pretreated with heparitinases that remove glycosaminoglycans from cell surfaces [85].